Renalytix Plc (LON:RENX – Get Free Report)’s stock price was down 2.8% on Wednesday . The company traded as low as GBX 8.50 ($0.11) and last traded at GBX 8.75 ($0.11). Approximately 323,879 shares were traded during trading, an increase of 23% from the average daily volume of 263,172 shares. The stock had previously closed at GBX 9 ($0.12).
Renalytix Stock Performance
The stock’s 50-day moving average price is GBX 10.15 and its 200-day moving average price is GBX 9.35. The company has a current ratio of 0.24, a quick ratio of 2.42 and a debt-to-equity ratio of -72.91. The company has a market capitalization of £35.23 million, a P/E ratio of -0.40 and a beta of 2.10.
About Renalytix
Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S.
Recommended Stories
- Five stocks we like better than Renalytix
- When to Sell a Stock for Profit or Loss
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- P/E Ratio Calculation: How to Assess Stocks
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
